MANAGEMENT: Richard Shea

DUKE INVENTOR: Bruce Sullenger

Basking Biosciences

Basking Biosciences is developing the first reversible thrombolytic therapy for acute ischemic stroke (AIS). The technology is based on two decades of translational research on RNA aptamers as therapeutic agents for cardiovascular diseases.